![Brian Colin Horsburgh](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Brian Colin Horsburgh
Chief Executive Officer at Modulate Therapeutics, Inc.
Profile
Brian Colin Horsburgh is the founder of Nurel Therapeutics, Inc. He is currently an Independent Director at Oil Spill Response Ltd.
and a Director at Modulate Therapeutics, Inc. He previously worked as a Director-Business Development at IP Group Plc, as well as a Director at Azellon Ltd.
and Amaethon Ltd.
Dr. Horsburgh obtained a doctorate degree from the University of Cambridge.
Brian Colin Horsburgh active positions
Companies | Position | Start |
---|---|---|
Modulate Therapeutics, Inc.
![]() Modulate Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Modulate Therapeutics, Inc. develops a medicine compound designed to re-engage the immune system in order to recognize and eradicate neoplastic disease. The company was founded by September 29, 2015 and is headquartered in Montréal, Canada. | Chief Executive Officer | - |
Oil Spill Response Ltd.
![]() Oil Spill Response Ltd. Environmental ServicesIndustrial Services Oil Spill Response Ltd. provides oil spill remediation services. The firm also provides business projects, training and consultancy services. The company was founded in 1981 is headquartered in London, the United Kingdom. | Director/Board Member | - |
Former positions of Brian Colin Horsburgh
Companies | Position | End |
---|---|---|
Amaethon Ltd.
![]() Amaethon Ltd. Miscellaneous Commercial ServicesCommercial Services Amaethon Ltd. commercializes plant and microbial science research. It audits, assesses, and protects Centre for Novel Agricultural Products' (CNAP) intellectual property and utilizes the Centre's research by developing relationships with industry and through the formation of spinouts. The firm is proactive in evaluating research progress in CNAP and identifying new intellectual property through regular IP surgeries with CNAP researchers. The company was founded in 2003 and is headquartered in York, the United Kingdom. | Director/Board Member | - |
IP GROUP PLC | Corporate Officer/Principal | - |
Nurel Therapeutics, Inc.
![]() Nurel Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nurel Therapeutics, Inc. was a biotechnology company. The company develops products to treat and manage pain and peripheral nerve damage and also develops products to vascular diseases. The company's products use a proprietary drug delivery technology derived from an 'inert' herpes simplex virus that provides gene based medicine. The company was headquartered in Pittsburgh, PA. | Founder | - |
Azellon Ltd.
![]() Azellon Ltd. Miscellaneous Commercial ServicesCommercial Services Azellon Ltd. develops stem cell therapy for the repair of avascular meniscal tears. The firm's meniscal repair technology combines bone marrow stem cells with a special membrane that helps to deliver the cells into the injured site. The company was founded by Anthony Hollander and Troels Jordansen in 2007 and is headquartered in London, the United Kingdom. | Director/Board Member | - |
Training of Brian Colin Horsburgh
University of Cambridge | Doctorate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
IP GROUP PLC | Commercial Services |
Private companies | 5 |
---|---|
Azellon Ltd.
![]() Azellon Ltd. Miscellaneous Commercial ServicesCommercial Services Azellon Ltd. develops stem cell therapy for the repair of avascular meniscal tears. The firm's meniscal repair technology combines bone marrow stem cells with a special membrane that helps to deliver the cells into the injured site. The company was founded by Anthony Hollander and Troels Jordansen in 2007 and is headquartered in London, the United Kingdom. | Commercial Services |
Nurel Therapeutics, Inc.
![]() Nurel Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nurel Therapeutics, Inc. was a biotechnology company. The company develops products to treat and manage pain and peripheral nerve damage and also develops products to vascular diseases. The company's products use a proprietary drug delivery technology derived from an 'inert' herpes simplex virus that provides gene based medicine. The company was headquartered in Pittsburgh, PA. | Health Technology |
Amaethon Ltd.
![]() Amaethon Ltd. Miscellaneous Commercial ServicesCommercial Services Amaethon Ltd. commercializes plant and microbial science research. It audits, assesses, and protects Centre for Novel Agricultural Products' (CNAP) intellectual property and utilizes the Centre's research by developing relationships with industry and through the formation of spinouts. The firm is proactive in evaluating research progress in CNAP and identifying new intellectual property through regular IP surgeries with CNAP researchers. The company was founded in 2003 and is headquartered in York, the United Kingdom. | Commercial Services |
Modulate Therapeutics, Inc.
![]() Modulate Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Modulate Therapeutics, Inc. develops a medicine compound designed to re-engage the immune system in order to recognize and eradicate neoplastic disease. The company was founded by September 29, 2015 and is headquartered in Montréal, Canada. | Health Technology |
Oil Spill Response Ltd.
![]() Oil Spill Response Ltd. Environmental ServicesIndustrial Services Oil Spill Response Ltd. provides oil spill remediation services. The firm also provides business projects, training and consultancy services. The company was founded in 1981 is headquartered in London, the United Kingdom. | Industrial Services |
- Stock Market
- Insiders
- Brian Colin Horsburgh